in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Daiichi Sankyo to sell API plant at Akita to Japanese firm
7:25 AM MDT | August 8, 2014 | Deepti Ramesh
Pharmaceutical company Daiichi Sankyo (Tokyo) says that it has reached an agreement with finished dosage forms producer Alfresa Pharma (Osaka) to sell the active pharmaceutical ingredient (API) plant at Akita, Japan, owned by the Daiichi Sankyo Propharma (DSPP; Tokyo) subsidiary, to Alfresa. Financial details of the agreement have not been disclosed. The transaction is expected to be completed on 1 April 2015. Daiichi Sankyo is restructuring its pharma ingredient subsidiaries. The company decided in 2012 to reorganize three of its supply chain subsidiaries in...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee